Pentoxifylline After Conservative Surgery for Endometriosis: A Randomized, Controlled Trial
article
OA: closed
CC0
⤵ 43 in-corpus citations
AI-generated summary
This randomized controlled trial investigated the efficacy of pentoxifylline in women undergoing conservative surgery for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Study objectiveTo compare outcomes after conservative surgery for endometriosis with and without pentoxifylline and to assess the efficacy of pentoxifylline in preventing recurrence of endometriosis after conservative surgery.DesignParallel-group, randomized, controlled trial (Canadian Task Force classification I).SettingTertiary care hospital.PatientsWomen undergoing conservative surgery for endometriosis.InterventionsLaparoscopic conservative surgery for endometriosis was completed by a single surgeon (J.A.T.), and all suspected endometriotic lesions were widely excised using monopolar coagulation and scissors. All specimens were submitted to pathology for confirmation of the diagnosis. Randomization to the treatment or control groups was completed preoperatively in the outpatient surgery unit by drawing colored marbles. A preoperative visual analog pain scale (VAS) was completed. After surgery, patients were discharged home with prescriptions for naproxen, hydromorphone, and pentoxifylline.Measurements and main resultsVisual analog scale scoring was completed monthly by each patient, and each patient was seen monthly for review and pelvic examination. Analgesic use was recorded daily using an individual medication log. Ongoing treatment choice after completion of the 3-month follow-up was recorded. The relationship between the group receiving pentoxifylline and the control group as well as analysis of the VAS scores at time of surgery and 1, 2, and 3 months postoperatively was determined using a covariate mixed-model ANOVA. Forty-nine patients were enrolled in the trial. One patient became pregnant before surgery, and 1 patient's chart was not available for analysis. Of the 47 who underwent conservative surgery for endometriosis, 9 (19%) had no endometriosis noted in the pathology specimens submitted. Two patients withdrew from the trial after surgery, and 2 patients were lost to follow-up after relocating to a different city. Nineteen women completed the 3-month follow-up in the control group, 15 in the group receiving pentoxifylline. The mean age, gravidity, parity, body mass index, previous surgery for endometriosis, menstrual cycle, and preoperative analgesic use did not differ significantly between the control and treatment groups. The time to complete the conservative surgery did not vary between the 2 groups. There were no intraoperative complications: two patients were admitted postoperatively, one for nausea and vomiting, one for pain that resolved 24 hours after admission. The VAS scores did not differ at the time of surgery; and in both the control and the pentoxifylline groups, there was significant improvement at each monthly interval (p <.05). The patients receiving pentoxifylline had significantly better VAS scores at 2 and 3 months after surgery (p <.03).ConclusionsThe use of pentoxifylline after conservative surgery for endometriosis resulted in improved VAS scores at 2 and 3 months after the procedure when compared with patients having conservative surgery only. The longer-term use of pentoxifylline after conservative surgery may improve long-term outcomes after surgical treatment for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (51)
- Changing concepts of medical treatment of endometriosis via openalex
- Changing concepts of medical treatment of endometriosis via crossref
- Combining medical and surgical treatment for endometriosis: the best of both worlds? via crossref
- Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease via openalex
- Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease via crossref
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up via crossref
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via crossref
- Immunologic Aspects of Human Endometriosis via openalex
- Immunologic Aspects of Human Endometriosis via crossref
- Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: a paradigm for a novel approach to the treatment of endometriosis-associated subfertility via crossref
- Laparoscopic endometriosis treatment: is it better? via openalex
- Laparoscopic endometriosis treatment: is it better? via crossref
- Laparoscopic endometriosis treatment: Is it better? via openalex
- Pain of endometriosis: effects of nafarelin and danazol therapy. via openalex
- Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study via crossref
- Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-α in women with endometriosis via openalex
- Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-α in women with endometriosis via crossref
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via openalex
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via crossref
- Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trial via crossref
- Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trial via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via crossref
- Second-look laparoscopy after laparoscopic cystectomy of large ovarian endometriomas via crossref
- Surgical treatment and adjunct therapy of endometriosis. via openalex
- [Tumor necrosis factor alpha and interferon gamma levels in peritoneal fluid of infertile women]. via openalex
- Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium via crossref
- W2012555822 via openalex
- W2026781016 via openalex
- doi:10.3109/01485019708987903 via crossref
- doi:10.1007/bf02212897 via crossref
- W2083603203 via openalex
- W2118832321 via openalex
- W2135754669 via openalex
- W2357844750 via openalex
- W2409439244 via openalex
- W2410450054 via openalex
- W2414422650 via openalex
- doi:10.1007/bf02212898 via crossref
- doi:10.1080/j.1600-0412.1998.770403.x via crossref
- W4239488741 via openalex
- W4313127696 via openalex
- W6607897346 via openalex
- W170259557 via openalex
- W141728048 via openalex
- doi:10.1189/jlb.71.4.588 via crossref
- doi:10.1016/s0024-3205(00)00419-7 via crossref
- W1965145195 via openalex
- W1990378054 via openalex
- W6718210757 via openalex
Cited by (43)
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Medikamentöse Therapie der Endometriose 2024
- Pentoxifylline for the treatment of endometriosis-associated pain and infertility 2021
- Treatment of endometriosis: a review with comparison of 8 guidelines 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Is Scientific Medical Literature Related to Endometriosis Treatment Evidence-Based? A Systematic Review on Methodological Quality of Randomized Clinical Trials 2019
- New therapeutic approaches for endometriosis besides hormonal therapy 2019
- Identifying Preoperative Factors Associated with Nonresponders in Women Undergoing Comprehensive Surgical Treatment for Endometriosis 2019
- Use of immunomodulators to treat endometriosis 2019
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- New developments in the medical treatment of endometriosis 2017
- A peek into the drug development scenario of endometriosis – A systematic review 2017
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- Oral Administration of Pentoxifylline Reduces Endometriosis-Like Lesions in a Nude Mouse Model 2016
- Chronic pelvic pain: Pathogenesis and validated assessment 2016
- On-label and off-label drug use in the treatment of endometriosis 2015
- Endometriosis: alternative methods of medical treatment 2015
- On-label and off-label drug use in the treatment of endometriosis 2015
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Vasodilators for women undergoing fertility treatment 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Endometriosis: An Update on Management 2013
- Antioxidants for female subfertility 2013
- Endometriosis: pathogenesis and treatment 2013
- An update on the pharmacological management of endometriosis 2013
- Antioxidants for female subfertility 2013
- Oxidative Stress and its Role in Endometriosis—Mechanistic and Therapeutic Implications 2012
- Pentoxifylline for endometriosis 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- Endometriosis: Current and Emerging Therapies 2011
- A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg 2011
- Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis 2011
- Pharmacological treatment of endometriosis: update from recent clinical trials 2011
- Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations 2010
- Management of Endometriosis-associated Pain 2010
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage and Recombinant Interleukin-2 Left in the Cysts: A Third Clinical Trial 2009
- Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model 2009
- Pentoxifylline versus medical therapies for subfertile women with endometriosis 2009
- Development and evaluation of two mouse models for endometriosis focused on the involvement of the immune system in endometriosis establishment 2008
- New drugs in development for the treatment of endometriosis 2008
- Emerging drugs for endometriosis 2008
Source provenance
- crossref
- last seen: 2026-08-13T06:47:03.146531+00:00
- europepmc
- last seen: 2026-08-17T06:11:01.428247+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:42.556217+00:00
- unpaywall
- last seen: 2026-08-17T06:25:09.426038+00:00
License: CC0
· commercial use OK